These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2409633)

  • 1. A F(ab')2 fragment blocking study of the HLA-B14 antigen.
    Darke C
    Tissue Antigens; 1985 Apr; 25(4):177-86. PubMed ID: 2409633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.
    Parham P
    Immunogenetics; 1983; 18(1):1-16. PubMed ID: 6190743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against an epitope common to HLA-b locus antigens.
    Billing R; Lucero K
    Hum Immunol; 1982 Jul; 4(4):351-7. PubMed ID: 6181038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-Bw65 with two major complotypes.
    Darke C; O'Neill GJ
    Tissue Antigens; 1987 Jul; 30(1):11-7. PubMed ID: 3672489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
    Ways JP; Parham P
    Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of responder cell activity in mixed leukocyte culture reactions. I. Evidence of cross-reactivity of B7-antibody with HLA-B8.
    de Rooij-Doyer E; Bruning JW; van Rood JJ
    Tissue Antigens; 1981 Sep; 18(3):154-65. PubMed ID: 7336421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inclusion of HLA-Bw42, Bw54 and Bw55 within the HLA-B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1983 Mar; 21(3):246-53. PubMed ID: 6190262
    [No Abstract]   [Full Text] [Related]  

  • 9. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HLA antigens on lymphoblastoid and epithelial cell lines and cross-reactivity of HLA-Cw5 and HLA-Cw8.
    O'Toole CM; Lewis CM; Wolf E
    Hum Immunol; 1983 Mar; 6(3):119-31. PubMed ID: 6841162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New evidence for the existence of HLA-B14 subtypes. Linkage with different DR antigens.
    Mueller-Eckhardt G; Mayr WR; Prel L; Mueller-Eckhardt C
    Tissue Antigens; 1983 Jan; 21(1):58-61. PubMed ID: 6404003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities.
    Street J; Darke C
    Int J Immunogenet; 2017 Oct; 44(5):225-233. PubMed ID: 28691368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytotoxic human hybridoma monoclonal antibody (TrJ5) specific for HLA-B38(16) and -B39(16).
    Ge J; Hannestad K
    Hum Immunol; 1993 Mar; 36(3):168-71. PubMed ID: 7686545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies.
    Williams RC; Malone CC; Silvestris F
    Clin Immunol Immunopathol; 1996 Aug; 80(2):194-203. PubMed ID: 8764565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking of HLA and B lymphocyte alloantigens with F (ab')2 fragments of rabbit antibodies.
    Billing RJ; Honig R; Peterson P; Safani M; Terasaki PI
    J Immunol; 1976 Nov; 117(5 Pt.2):2040-2. PubMed ID: 62805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HLA-B alleles associated with antigens in the 8C CREG.
    Steiner NK; Gans CP; Kosman C; Baldassarre LA; Edson S; Jones PF; Rizzuto G; Pimtanothai N; Koester R; Mitton W; Ng J; Hartzman RJ; Hurley CK
    Tissue Antigens; 2001 Apr; 57(4):373-5. PubMed ID: 11380951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fab2 fragments from HLA xenoantisera specifically block cytolysis mediated by HLA-AB alloantisera.
    Belvedere M; Richiardi P; Pellegrino MA; Ferrone S
    J Immunogenet; 1980 Jun; 7(3):215-9. PubMed ID: 6157749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of LMTK- cells with purified class I genes. V. Antibody-induced structural modification of HLA class I molecules results in potentiation of the fixation of a second monoclonal antibody.
    Lemonnier FA; Le Bouteiller PP; Olive D; Malissen B; Mishal Z; Layet C; Dubreuil J; Caillol DH; Kourilsky FM; Jordan BR
    J Immunol; 1984 Mar; 132(3):1176-82. PubMed ID: 6198381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of monoclonal antibodies against HLA-A2 is due to antibody bivalency.
    Holmes NJ; Parham P
    J Biol Chem; 1983 Feb; 258(3):1580-6. PubMed ID: 6185487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.